Locations:
SearchAdvertisement
Timing of adjuvant immunotherapy unclear for maximum overall survival
Treatment decision must be balanced against toxicity concerns
Genomic adjusted radiation dose guides treatment decision making
Use of tool can change recommendation to add or omit radiation
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
What is the role of molecular profiling in risk stratification?
Multidisciplinary team to examine radiation therapy combined with immunotherapy
Struma ovarii can give rise to uncommon malignancy
Majority of patients achieve complete pathologic response after four-dose cemiplimab therapy
Early diagnosis and referral to a multidisciplinary team are essential
Advertisement
Advertisement
